| Date |
Headline |
Summary |
| 2013-05-10 08:23:51 |
Lumigan...Can do Wonders in Your Eyelashes, but here's some lead |
Thick and long eyelashes can undeniably work wonders in the overall silhouette of your face. Like our eyelashes, beauty does not possess long-lasting security because of external and natural factors such as age, pollution and global warming.. |
| 2013-04-26 05:15:48 |
Evista for prevention of breast cancer |
Can the drug for osteoporosis treatment Evista prevent breast cancer in the high-risk group?
|
| 2013-04-23 08:47:11 |
Plavix can help your heart |
As researchers say, an enormous progress can be achieved in the treatment of heart diseases using a heart drug Plavix, in combination with aspirin. |
| 2011-03-27 05:56:25 |
EMEA approved the drug Gilenya |
The European Medicines Agency (EMEA) has approved the drug Gilenya (fingolimod capsules) - Europe's first drug used for oral administration for treatment of multiple sclerosis.
The drug is indicated for the treatment of patients with progressive remitting multiple sclerosis treated when treatment by β-interferons is insufficient or in patients with relapsing-remitting fast-progressive severe multiple sclerosis.
|
| 2010-07-17 09:23:03 |
FDA approved a new medicine Sprix |
The US Food and Drug Administration approved the drug Sprix (ketorolac trometamin) in the form of nasal spray for short-term treatment of moderate and severe pain. Nasal spray Sprix contains nonsteroidal anti-inflammatory drug (NSAID) ketorolac. This non-narcotic medication minimizes the risk of abuse and non-medicinal use and also reduces the risk of serious side effects.
The medicine should not be used for more than 5 days. Also, Sprix is contraindicated in patients with peptic ulcer disease and renal insufficiency. |
| 2010-06-22 12:13:55 |
British scientists have developed a new drug for breast cancer |
Recently at a medical conference in Chicago British researchers have shown a new chemical called eribulin. Eribilin is natural compound obtained from marine sponge. Clinical and laboratory analyses showed that eribulin can help to prolong the life of women suffering from breast cancer at late stage. Previously eribulin was known as E7389 or NSC-707389 and is being investigated by Eisai Co.
Eribulin is a synthetic macrocyclic ketone being analogue of the marine sponge - natural product halichondrin B The scientists showed that Eribulin mimics a component that prevents cell division of sponges. |
| 2010-06-22 12:09:15 |
Deficiency of vitamin D is closely related to diabetes and metab |
The researchers from Johns Hopkins University in Baltimore examined 124 medical charts of patients with diabetes first and second type in the period from 2003 to 2008. The scientists found that more than 90% of patients with diabetes had a low blood level of vitamin D despite regular medical checkups (vitamin D was prescribed only for 6% of patients). The researchers noticed that patients which didn't took vitamin D preparations had a higher level of blood sugar. |
| 2010-06-22 12:05:52 |
Obesity during pregnancy is dangerous for the child |
According to a new study conducted by British scientists children whose mothers gained a lot of extra pounds during pregnancy are at high risk of obesity and cardiovascular diseases.
The study involved nearly 7000 pregnant women and their children under 9 years of age. It was found that children whose mothers gained more than recommended extra pound were at higher risk of high blood pressure. Moreover, these children were at high risk of overweight and hypercholesterolemia – condition that predisposes to atherosclerosis.
|
| 2010-05-16 13:05:30 |
Vimovo. Vimovo has been approved by FDA. Vimovo drug information |
Recently Food and Drug Administration USA approved Vimovo containing naproxen and esomeprasol for treating patients with arthritis with increased risk if NSAID-associated gastric ulcers. Vimovo is used to relieve symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, as well as to reduce the risk of stomach ulcers in patients with high risk of developing NSAID-associated ulcers |
| 2010-02-12 13:09:54 |
Moderate physical activity can help with gallbladder stones |
According to a study conducted by British researchers, people who sufficiently practice sports, suffer from painful gallstones much rarely.
The researchers analyzed data from 25 000 men and women and found that the most physically active of them the of risk of cholelithiasis symptoms was 70% less than in inactive patients.
In addition, the experts found that about 17% of cases of cholelithiasis, which required as surgical intervention could have prevented by increased physical activity. |
| 2010-02-12 13:02:28 |
Can Internet addiction lead to depression? |
According to a study conducted by British scientists, people who devote much of their time "surfing" in the network, may be prone to develop depression. Especially those people which replace live communication to different chats rooms and social networks. Undoubtedly, the Internet plays a significant role in modern life, makes it possible to find almost any information, to communicate with people in different countries and so on |
| 2010-02-12 12:56:27 |
Migraine can be associated with an increased risk of myocardial |
According to a new study, people who suffer from migraines, are at greater risk of myocardial infarction. However, the direct mechanism of this relationship has not been found.
According to a study conducted by scientists at the Medical College Albert Einstein in New York the frequency of heart attacks in people who suffer from migraines is 2 times higher than in healthy adults.
|
| 2010-02-06 13:59:23 |
FDA approved the drug Victoza for the treatment of diabetes type |
US Food and Drug Administration USA (FDA) approved the drug Victoza (liraglutide) for the treatment of diabetes type 2. Victoza is made by one of the largest pharmaceutical companies in Denmark, Novo Nordisk. Victoza is available in the form of injection and used once a day for the treatment of type 2 diabetes.
|
| 2010-01-25 14:21:20 |
FDA approved Ampyra in patients with multiply sclerosis |
FOOD and DRUG Administration has approved a new medication Ampyra (dalfampridine) in the form of extended release drugs tablets to improve walking in patients multiple sclerosis. Clinical studies have shown that Ampyra can significantly increase the speed with which patients can walk, compared with placebo. Ampyra is the first drug with such indication approved by the FDA.
|
| 2010-01-25 14:17:33 |
Obesity can significantly increase the risk of kidney cancer |
According to a new study conducted by American scientists, obesity can increase the risk of kidney cancer. The study involved 1640 patients aged 62 years with kidney tumors. Scientists found that the risk of renal cell carcinoma is much higher (nearly by 48%) in patients with obesity than in patients with a body mass index less than 30 (threshold for obesity). Malignant formation of renal cell carcinoma was found in 67% of patients with obesity.
|
| 2010-01-19 13:45:10 |
Mediterranean diet may help to reduce the risk of stomach cancer |
According to research conducted by Spanish scientists, the Mediterranean diet can significantly reduce the risk of developing adenocarcinoma of the stomach. The researchers studied the materials received from nearly 500 thousand inhabitants of 10 European countries between the ages of 35 to 70 years.
|
| 2010-01-19 13:41:40 |
Stelara - new effective medication for psoriasis treatment |
New drug for the treatment of psoriasis - ustekinumab (Stelara), according to the results of research ustekinumab (Stelara) is more effective than standard therapy with Etanercept. Stelara quickly begins working and its effect is more expressed compared with etanercept, - says the professor of dermatology department at Manchester University, Christopher Griffiths. Stelara contains human monoclonal antibodies active against interleukin 12 and 23.
|
| 2010-01-10 10:45:44 |
Serotonin reuptake inhibitors may increase the risk of gastroint |
According to the research of Danish scientists, serotonin reuptake inhibitors (SSRIs) increase the risk of bleeding of upper gastrointestinal tract (GIT), which is caused by their ability to block platelet aggregation.
Such conclusions were made by scientists on the basis of data analysis 3652 patients diagnosed with severe upper gastrointestinal bleeding.
|
| 2010-01-10 10:39:44 |
Are antidepressants effective only in severe depression? |
According to a study conducted by scientists at the University of Pennsylvania, antidepressant drugs have an exressed clinical effect only in severe forms of depression.
|
| 2008-04-20 11:00:00 |
Yasmin is as one of the most popular oral contraceptives worldwi |
Head count results showed that Yasmin is used by four millions of women in 72 countries of the world. Interviews also showed that the main reason why one woman out of three preferred Yasmin instead of other contraceptives is that there is no body weight gain in using it. |
